KEGG   DISEASE: Immunodeficiency, developmental delay, and hypohomocysteinemia
Entry
H03069                      Disease                                
Name
Immunodeficiency, developmental delay, and hypohomocysteinemia
Description
Immunodeficiency, developmental delay, and hypohomocysteinemia (IMDDHH) is an early-onset multisystem disorder characterized by failure to thrive, immunodeficiency, and neurological symptoms. The unique combination of white matter lesions, hypohomocysteinaemia, and increased G-6-P-dehydrogenase activity will facilitate early diagnosis and therapeutic intervention. It has been reported that activating de novo mutations in NFE2L2, which encodes NRF2, cause this disease. NRF2 is a transcription factor that regulates the expression of more than 200 genes. It is suggested that NRF2 accumulation leads to widespread misregulation of gene expression and an imbalance in cytosolic redox balance.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C50  Inborn errors of amino acid or other organic acid metabolism
     H03069  Immunodeficiency, developmental delay, and hypohomocysteinemia
Gene
NFE2L2 [HSA:4780] [KO:K05638]
Other DBs
ICD-11: 5C50.5
OMIM: 617744
Reference
  Authors
Huppke P, Weissbach S, Church JA, Schnur R, Krusen M, Dreha-Kulaczewski S, Kuhn-Velten WN, Wolf A, Huppke B, Millan F, Begtrup A, Almusafri F, Thiele H, Altmuller J, Nurnberg P, Muller M, Gartner J
  Title
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.
  Journal
Nat Commun 8:818 (2017)
DOI:10.1038/s41467-017-00932-7
LinkDB

» Japanese version

DBGET integrated database retrieval system